Abstract:Background Brain ageing is highly heterogeneous, as it is driven by a variety of normal and neuropathological processes. These processes may differentially affect structural and functional brain ageing across individuals, with more pronounced ageing (older brain age) during midlife being indicative of later development of dementia. Here, we examined whether brain-ageing heterogeneity in unimpaired older adults related to neurodegeneration, different cognitive trajectories, genetic and amyloid-beta (A beta) profiles, and to predicted progression to Alzheimer's disease (AD). Methods Functional and structural brain age measures were obtained for resting-state functional MRI and structural MRI, respectively, in 3460 cognitively normal individuals across an age range spanning 42-85 years. Participants were categorised into four groups based on the difference between their chronological and predicted age in each modality: advanced age in both (n = 291), resilient in both (n = 260) or advanced in one/resilient in the other (n = 163/153). With the resilient group as the reference, brain-age groups were compared across neuroimaging features of neuropathology (white matter hyperintensity volume, neuronal loss measured with Neurite Orientation Dispersion and Density Imaging, AD-specific atrophy patterns measured with the Spatial Patterns of Abnormality for Recognition of Early Alzheimer's Disease index, amyloid burden using amyloid positron emission tomography (PET), progression to mild cognitive impairment and baseline and longitudinal cognitive measures (trail making task, mini mental state examination, digit symbol substitution task). Findings Individuals with advanced structural and functional brain-ages had more features indicative of neurodegeneration and they had poor cognition. Individuals with a resilient brain-age in both modalities had a genetic variant that has been shown to be associated with age of onset of AD. Mixed brain-age was associated with selective cognitive deficits. Interpretation The advanced group displayed evidence of increased atrophy across all neuroimaging features that was not found in either of the mixed groups. This is in line with biomarkers of preclinical AD and cerebrovascular disease. These fi ndings suggest that the variation in structural and functional brain ageing across individuals reflects the degree of underlying neuropathological processes and may indicate the propensity to develop dementia in later life. Funding The National Institute on Aging, the National Institutes of Health, the Swiss National Science Foundation, the Kaiser Foundation Research Institute and the National Heart, Lung, and Blood Institute. Copyright (c) 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

BrainAGE, Brain Health, and Mental Disorders: a Systematic Review

Brain-age in midlife is associated with accelerated biological aging and cognitive decline in a longitudinal birth cohort

Brain-age prediction: Systematic evaluation of site effects, and sample age range and size

Brain Age Estimation on a Dementia Cohort Using FLAIR MRI Biomarkers

Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study

BrainAGE: Revisited and reframed machine learning workflow

Estimated Brain Age in Healthy Aging and Across Multiple Neurological Disorders

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease

Probing the Biological Underpinnings of Advanced Brain Ageing in Schizophrenia

A review of artificial intelligence-based brain age estimation and its applications for related diseases

Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study

The Relationship Between Cerebral Glucose Metabolism and Age: Report of A Large Brain Pet Data Set

Cross-sectional brain age assessments are limited in predicting future brain change

The Link between Brain age and Alzheimer’s Disease development using different neuroimaging modalities

Evaluation of Brain Age as a Specific Marker of Brain Health

Older molecular brain age in severe mental illness

Brain age and other bodily ‘ages’: implications for neuropsychiatry

Relationship Between MRI Brain-Age Heterogeneity, Cognition, Genetics and Alzheimer’s Disease Neuropathology

Brain aging patterns in a large and diverse cohort of 49,482 individuals

Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group

Ageing Biomarkers Derived From Retinal Imaging: A Scoping Review